2024-10-22 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis Report

**1. Performance Comparison:**

Abbott Laboratories (ABT) is a multinational healthcare company that develops, manufactures, and markets a wide range of healthcare products.

As of today, ABT's cumulative return is 109.55%, while the S&P 500 (VOO) has a cumulative return of 136.39%. This means ABT has underperformed the S&P 500 by 26.84%. The relative divergence (15.18%) indicates that ABT is currently performing in the lower 15.18% percentile of its historical performance relative to the S&P 500.

**2. Recent Price Action:**

* Closing Price: $117.04
* 5-day Moving Average: $117.83
* 20-day Moving Average: $115.12
* 60-day Moving Average: $113.31

ABT's price has been relatively stable recently, trading slightly above its 20-day and 60-day moving averages. The 5-day moving average indicates a slight downward trend.

**3. Technical Indicators:**

* RSI: 62.46
* PPO: 0.18
* Recent (20-day) Relative Divergence: 1.95 (positive)
* Expected Return: 0.0%

The RSI suggests ABT is in moderately overbought territory. The PPO is positive, indicating upward momentum. The recent relative divergence suggests that ABT's price is starting to move in line with the market, with some positive momentum. The expected return of 0.0% suggests that ABT is expected to perform in line with the S&P 500 over the long term.

**4. Recent Earnings and Outlook:**

| Date      | EPS | Revenue          |
|-----------|-----|-------------------|
| 2024-07-31 | 0.74 | $10.38 Billion  |
| 2024-05-02 | 0.7  | $9.96 Billion   |
| 2023-11-01 | 0.82 | $10.14 Billion  |
| 2023-08-03 | 0.79 | $9.98 Billion   |
| 2024-07-31 | 0.79 | $9.98 Billion   |

The most recent earnings report (2024-07-31) showed EPS of $0.74, slightly exceeding analysts' expectations. Revenue was also slightly above expectations. Overall, ABT has consistently delivered strong earnings, with a slight dip in revenue during the past quarter.

**5. News and Recent Issues:**

Recent market outlook for ABT remains positive, with analysts citing its strong earnings track record, diversified product portfolio, and growth potential in emerging markets. While some concerns remain regarding competition and the potential for price pressures in certain segments, ABT is generally seen as a solid investment opportunity.

**6. Conclusion:**

ABT has been a consistent performer, with a solid track record of growth and earnings. While the stock has underperformed the S&P 500 in the recent past, it shows positive momentum and potential for growth in the long term. Its recent earnings report was positive, exceeding expectations and providing further support for its future prospects. 

However, investors should be aware of the potential for competition and price pressures in certain segments, and monitor its performance closely to assess its long-term growth potential.
